Home > Financial Ratios > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for BAFNA PHARMACEUTICALS
Please provide your vote to see the results

BAFNA PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -4.88-22.9339.0023.66644.34

What is the latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of BAFNA PHARMACEUTICALS is -4.88 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-4.88
Mar2024-22.93
Mar202339.00
Mar202223.66
Mar2021644.34

How is Core EBITDA Growth of BAFNA PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 -4.88
Negative
Mar2024 -22.93
Negative
Mar2023 39
64.84
Mar2022 23.66
-96.33
Mar2021 644.34 -

Other Financial Ratios of BAFNA PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹366.4 Cr -0.4% 3.5% 88.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,319.0 Cr 2.4% -2.5% -7.9% Stock Analytics
DIVIS LABORATORIES ₹176,383.0 Cr 3.9% 2.6% 3.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,241.0 Cr 2.5% 4.1% 12.3% Stock Analytics
CIPLA ₹123,617.0 Cr 1.3% 0.6% -1.2% Stock Analytics
DR REDDYS LABORATORIES ₹104,825.0 Cr -1.2% -1.5% -9.1% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

-0.4%

3.5%

88.7%

SENSEX

0.5%

-0.2%

8.4%


You may also like the below Video Courses